Who are GT Biopharma, Inc.'s main suppliers?

GT Biopharma, Inc. (GTBP) key suppliers include: UNIVERSITY-OF-MINNESOTA, VENDOR. View the full supplier network at chainsifter.com/chain/GTBP.

Who are GT Biopharma, Inc.'s major customers?

GT Biopharma, Inc. (GTBP) key customers include: REGENTS-OF-THE-UNIVERSITY-OF-MINNESOTA, GEORGETOWN-TRANSLATIONAL-PHARMACEUTICALS-INC, OXIS-BIOTECH-INC. View the full customer network at chainsifter.com/chain/GTBP.

What sector is GT Biopharma, Inc. in?

GT Biopharma, Inc. (GTBP) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

GTBP Supply Chain: GT Biopharma, Inc. Suppliers & Customers

2Suppliers

3Customers

2Debt Items

0Related Chains

GT Biopharma, Inc. Suppliers

Ticker	Name	Confidence	Evidence
UNIVERSITY-OF-MINNESOTA	UNIVERSITY-OF-MINNESOTA	92%	The Company entered into an exclusive license agreement with the University of Minnesota
VENDOR	VENDOR	92%	On June 30, 2024, the Company issued 91,579 shares of common stock to settle $531,300 of vendor accounts payable.

GT Biopharma, Inc. Customers

Ticker	Name	Confidence	Evidence
REGENTS-OF-THE-UNIVERSITY-OF-MINNESOTA	REGENTS-OF-THE-UNIVERSITY-OF-MINNESOTA	92%	On April 3, 2026, GT Biopharma, Inc., a Delaware corporation (the “Company”), entered into an Investigator Initiated Clinical Trial Agreement (the “Agreement”) with the Regents of the University of M…
GEORGETOWN-TRANSLATIONAL-PHARMACEUTICALS-INC	GEORGETOWN-TRANSLATIONAL-PHARMACEUTICALS-INC	62%	. The GT Biopharma logo, TriKE®, and other trademarks or service marks of GT Biopharma, Inc. appearing in this quarterly report are the property of the Company. This Annual Report on Form 10-K also c…
OXIS-BIOTECH-INC	OXIS-BIOTECH-INC	62%	. The GT Biopharma logo, TriKE®, and other trademarks or service marks of GT Biopharma, Inc. appearing in this quarterly report are the property of the Company. This Annual Report on Form 10-K also c…

GT Biopharma, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
GTBP-DEBT-9914	Warrants outstanding: 21145	90%	xbrl warrant detail from xbrl 2025-12-31.
GTBP-DEBT-9915	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2022-12-31.

GT Biopharma, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for GT Biopharma, Inc..

GT Biopharma, Inc. Ownership

Holder	Name	Confidence	Evidence
GTBP-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 41 tracked holders.

GT Biopharma, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

GT Biopharma, Inc. Supply Chain